Jbm (Healthcare) Ltd
HKEX:2161

Watchlist Manager
Jbm (Healthcare) Ltd Logo
Jbm (Healthcare) Ltd
HKEX:2161
Watchlist
Price: 2.72 HKD -2.16% Market Closed
Market Cap: 2.2B HKD

Jbm (Healthcare) Ltd
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jbm (Healthcare) Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Jbm (Healthcare) Ltd
HKEX:2161
Income from Continuing Operations
HK$202.7m
CAGR 3-Years
106%
CAGR 5-Years
36%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Income from Continuing Operations
HK$2.1B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
27%
U
United Laboratories International Holdings Ltd
HKEX:3933
Income from Continuing Operations
ÂĄ3.1B
CAGR 3-Years
45%
CAGR 5-Years
41%
CAGR 10-Years
31%
Sino Biopharmaceutical Ltd
HKEX:1177
Income from Continuing Operations
ÂĄ6.8B
CAGR 3-Years
-30%
CAGR 5-Years
8%
CAGR 10-Years
12%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Income from Continuing Operations
HK$7.9B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Income from Continuing Operations
$467.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
56%
No Stocks Found

Jbm (Healthcare) Ltd
Glance View

Market Cap
2.2B HKD
Industry
Pharmaceuticals

JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 274 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Intrinsic Value
4.35 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Jbm (Healthcare) Ltd's Income from Continuing Operations?
Income from Continuing Operations
202.7m HKD

Based on the financial report for Mar 31, 2025, Jbm (Healthcare) Ltd's Income from Continuing Operations amounts to 202.7m HKD.

What is Jbm (Healthcare) Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
36%

Over the last year, the Income from Continuing Operations growth was 48%. The average annual Income from Continuing Operations growth rates for Jbm (Healthcare) Ltd have been 106% over the past three years , 36% over the past five years .

Back to Top